Ophthalmic Artery Injection For Retinoblastoma Is Effective

November 1, 2011

Ophthalmology: Selective ophthalmic artery injection of chemo (melphalan) for retinoblastoma was successfully performed in 98% of cases, saving about 50% of eyes, and preserving vision in those without macular involvement. No serious local or systemic side effects were encountered.




Jump down to form below to submit your own comments

Trackback URL

Have insights to contribute? Please submit your comment below